Brief: Mendus Announces Updated Clinical Strategy, Operational Focus
Oct 2 (Reuters) - Mendus AB (publ) IMMUN.ST: MENDUS ANNOUNCES UPDATED CLINICAL STRATEGY AND OPERATIONAL FOCUS WILL REDUCE ITS STAFF FROM 28 TO 19, INCLUDING AN ADJUSTMENT OF COMPANY'S EXECUTIVE MANAGEMENT TEAM FROM 5 TO 3 MEMBERS SAVINGS REALIZED BY CORPORATE REORGANIZATION ARE ESTIMATED TO OFFSET EXTRA TRIAL COSTS ANTICIPATED FOR 2026 Source text: ID:nMFN5x1Dbf Further company coverage: IMMUN.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))